Literature DB >> 11498721

Physiological, subjective and reinforcing effects of oral and intravenous cocaine in humans.

B J Smith1, H E Jones, R R Griffiths.   

Abstract

RATIONALE: There is little comparative information on the qualitative similarity, relative potency and reinforcing effects of oral cocaine versus cocaine administered via other routes.
METHODS: The present study used a within-subject, double-blind, double-dummy design to compare the physiological, subjective and reinforcing effects of placebo and oral (62.5, 125, 250 mg/70 kg) and intravenous (IV) (12.5, 25, 50 mg/70 kg) cocaine in volunteers with histories of cocaine abuse.
RESULTS: Cocaine produced dose-dependent increases on heart rate and blood pressure, with effects lasting longer after oral than IV cocaine. Subjective ratings (e.g., "rush," "drug effect," "liking") were qualitatively similar and dose-dependently increased after oral and IV administration, and the duration of effects was similar under both routes. On a money versus drug choice measure of reinforcement, the monetary amounts at which participants chose drug over money increased as a function of cocaine dose under both routes of administration. At doses that produced comparable subjective, physiological, and reinforcing effects, oral cocaine was not identified as cocaine as frequently as IV cocaine. Across measures, the data suggested that IV cocaine was approximately 10 times more potent than oral cocaine.
CONCLUSIONS: Overall, the results of this study support qualitatively similar effects of oral and IV cocaine and suggest that oral cocaine may be an effective tool for studying cocaine's effects in human laboratory studies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11498721     DOI: 10.1007/s002130100740

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  13 in total

1.  Imaging cocaine-induced changes in the mesocorticolimbic dopaminergic system of conscious rats.

Authors:  Marcelo Febo; Annabell C Segarra; Jeffrey R Tenney; Mathew E Brevard; Timothy Q Duong; Craig F Ferris
Journal:  J Neurosci Methods       Date:  2004-10-30       Impact factor: 2.390

2.  Cocaine administration dose-dependently increases sexual desire and decreases condom use likelihood: The role of delay and probability discounting in connecting cocaine with HIV.

Authors:  Matthew W Johnson; Evan S Herrmann; Mary M Sweeney; Robert S LeComte; Patrick S Johnson
Journal:  Psychopharmacology (Berl)       Date:  2016-12-05       Impact factor: 4.530

3.  Rapid delivery of cocaine facilitates acquisition of self-administration in rats: an effect masked by paired stimuli.

Authors:  Charles W Schindler; Elizabeth S Cogan; Eric B Thorndike; Leigh V Panlilio
Journal:  Pharmacol Biochem Behav       Date:  2011-05-11       Impact factor: 3.533

4.  Different lengths of times for progressions in adolescent substance involvement.

Authors:  Ty A Ridenour; Stephanie T Lanza; Eric C Donny; Duncan B Clark
Journal:  Addict Behav       Date:  2006-05-04       Impact factor: 3.913

Review 5.  Immunotherapy for drug abuse.

Authors:  Xiaoyun Shen; Thomas R Kosten
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-12       Impact factor: 4.388

6.  Novelty-induced locomotion is positively associated with cocaine ingestion in adolescent rats; anxiety is correlated in adults.

Authors:  Q David Walker; Nicole L Schramm-Sapyta; Joseph M Caster; Samuel T Waller; Matthew P Brooks; Cynthia M Kuhn
Journal:  Pharmacol Biochem Behav       Date:  2008-08-28       Impact factor: 3.533

7.  Repeated dosing with oral cocaine in humans: assessment of direct effects, withdrawal, and pharmacokinetics.

Authors:  Sharon L Walsh; William W Stoops; David E Moody; Shen-Nan Lin; George E Bigelow
Journal:  Exp Clin Psychopharmacol       Date:  2009-08       Impact factor: 3.157

Review 8.  Vaccines against stimulants: cocaine and MA.

Authors:  Thomas Kosten; Coreen Domingo; Frank Orson; Berma Kinsey
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

Review 9.  The future potential for cocaine vaccines.

Authors:  Frank M Orson; Rongfu Wang; Stephen Brimijoin; Berma M Kinsey; Rana Ak Singh; Muthu Ramakrishnan; Helen Y Wang; Thomas R Kosten
Journal:  Expert Opin Biol Ther       Date:  2014-05-16       Impact factor: 4.388

10.  Evidence for habitual and goal-directed behavior following devaluation of cocaine: a multifaceted interpretation of relapse.

Authors:  David H Root; Anthony T Fabbricatore; David J Barker; Sisi Ma; Anthony P Pawlak; Mark O West
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.